Evidence map›Paper›PMID 40079124›Full record

ArticleInternational health2025

Assessment of compliance with tetracycline eye ointment treatment to accelerate the elimination of trachoma in Yobe State, Nigeria.

Juliana A Amanyi-Enegela, Rinpan Ishaya, Joseph Kumbur, Girija Sankar, William Enan Adamani, Christopher Ogoshi, Nicholas Olobio, Muhammad Babar Qureshi, Caleb Mpyet

Abstract read
In one paragraph

Article in International health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Juliana A Amanyi-EnegelaInclusive Eye Health and Neglected Tropical Diseases Initiative, CBM Christoffel-Blindenmission Christian Blind Mission e.V, CB1 1BH Cambridge, UK.ORCID 0000-0002-2565-4735
Rinpan IshayaHANDS, 5A Naomi Jugu Drive, 930103 Rayfield, Jos, Plateau State, Nigeria.
Joseph KumburCBM Christoffel-Blindenmission, Christian Blind Mission e.V Nigeria Country Office, Abuja, Nigeria.
Girija SankarInclusive Eye Health and Neglected Tropical Diseases Initiative, CBM Christoffel-Blindenmission Christian Blind Mission e.V, CB1 1BH Cambridge, UK.
William Enan AdamaniCBM Christoffel-Blindenmission, Christian Blind Mission e.V Nigeria Country Office, Abuja, Nigeria.
Christopher OgoshiHANDS, 5A Naomi Jugu Drive, 930103 Rayfield, Jos, Plateau State, Nigeria.
Nicholas OlobioNeglected Tropical Diseases Unit, Federal Ministry of Health, PMB 083 Abuja, Nigeria.
Muhammad Babar QureshiInclusive Eye Health and Neglected Tropical Diseases Initiative, CBM Christoffel-Blindenmission Christian Blind Mission e.V, CB1 1BH Cambridge, UK.
Caleb MpyetDepartment of Ophthalmology, 930003, University of Jos, Plateau State, Nigeria.

Funding

International Trachoma InitiativeRoyal Society of Tropical Medicine and Hygiene
6 · The paper itself

Abstract

backgroundTrachoma, a neglected tropical disease, remains a significant public health concern in many regions, particularly in sub-Saharan Africa and in Yobe State, Nigeria. One approach for elimination involves administering tetracycline eye ointment (TEO) to children <6 months of age as part of annual mass drug administration (MDA), aligning with the World Health Organization's 'A' component of the SAFE (Surgery, Antibiotics, Facial hygiene and Environmental sanitation) strategy for elimination of trachoma as a public health problem. However, suboptimal compliance rates in affected populations pose challenges, potentially serving as a reservoir for reinfection and hindering progress toward trachoma elimination. This study focuses on assessing compliance with topical TEO during MDA and explores strategies to enhance adherence in trachoma-endemic areas of Yobe State, Nigeria.

methodsA mixed research approach was carried out involving interviews with households across 30 communities in five local government areas where TEO was administered during the 2022 round of MDA. Focus group discussions were conducted with subsets of the population who received TEO to gain insights into the underlying reasons for non-compliance and ways to improve compliance. Additionally, healthcare provider perspectives on treatment administration, compliance and community health education were explored.

resultsFindings from this study show that there is already a high level of compliance with TEO usage, however, forgetfulness due to competing domestic chores, insufficient quantity of TEO given for 6-week applications, low awareness about the impact of trachoma infection on the eyes and the stinging feeling after application, especially in children <6 months of age, are some barriers that affect TEO usage compliance. Following up with TEO recipients would remind them to use the ointment as required, while incentivizing health workers and community drug distributors to conduct follow-up visits to households, increasing awareness on the impact of trachoma on the eyes. Increasing the quantity of TEO allocation would also improve compliance.

conclusionsYobe State has made remarkable progress towards eliminating trachoma as a public health problem, as 12 local government areas no longer require MDA. Sustaining this momentum means ensuring high compliance among the population eligible to receive TEO to prevent any reservoir for reinfection in the state.

Indexed as

Anti-Bacterial AgentsTetracyclineTrachomaFemaleFocus GroupsHumansInfantMaleMass Drug AdministrationNigeriaOintmentsAnti-Bacterial AgentsOintmentsTetracyclineeliminationneglected tropical diseasesNigeriatetracycline eye ointment (TEO)trachomatreatment complianceYobe State

Identifiers

PMID40079124
PMCPMC12406771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.